Acne VulgarisNCT00441805
The Treatment of Acne Vulgaris With Radiofrequency Device
A study testing Radio Frequency in people with Acne Vulgaris, run by Alma Lasers at 1 site in Israel.
Trial summary
Radiofrequency emmitting device, normaly used for thermage treatments will be used on 22 mild to moderate acne patients faces. The aim of the study is to check whether RF heating of subcutaneous and dermis will improve acne in needed patients. Read more about this study
- Who is it for?
- Ages 18 to 100 yearsHealthy volunteers can take part
- Conditions the study is for
- Acne Vulgaris
- What is being tested?
- Radio Frequency
- Type of treatment
- Medical device
- How many people
- 0 participants
- Where
- 1 siteIsrael
- Study dates
- Nov 2006to Sep 2007
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- mild-moderate Acne
- age over 18
- otherwise healthy
Who cannot join
- age under 18
- pregnancy
- systemic acne treatment in the last month
- local acne treatment in the last month
Trial locations and contacts
1 site in 1 country.
About this study
Radiofrequency emmitting device, normaly used for thermage treatments will be used on 22 mild to moderate acne patients faces.
The aim of the study is to check whether RF heating of subcutaneous and dermis will improve acne in needed patients.
- Conditions
- Acne Vulgaris
- Being tested
- Radio Frequency
- Keywords
- Acne, RadioFrequency
- Medical subject headings
- Acne Vulgaris
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Radio FrequencyDevice
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Mar 2007 (estimated)
- Study startNov 2006 (estimated)
- Primary completionSep 2007 (estimated)
- Study completionSep 2007 (estimated)
Why it stopped: Terminated- the study was not started (per Investigator's/sponsor decision)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acne VulgarisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Alma Lasers
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Yussi Levcelter, Dr., Study director, Alma Lasers LTD
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00441805
- Sponsor's protocol ID
- AL-RF/ACN02/06IL CTIL
- Status last verified
- Oct 2020
- First submitted
- 27 Feb 2007
- Last updated
- 9 Oct 2020
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Treatment of Acne Vulgaris With Radiofrequency Device
- ClinicalTrials.gov ID
- NCT00441805
- Acronym / sponsor ID
- AL-RF/ACN02/06IL CTIL
- Conditions
- Acne Vulgaris
- Keywords
- Acne, RadioFrequency
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Terminated- the study was not started (per Investigator's/sponsor decision)
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Alma LasersIndustry (pharma, biotech, devices)
- Study start
- Nov 2006 (estimated)
- Primary completion
- Sep 2007 (estimated)
- Study completion
- Sep 2007 (estimated)
- First posted
- 1 Mar 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Radiofrequency emmitting device, normaly used for thermage treatments will be used on 22 mild to moderate acne patients faces.
The aim of the study is to check whether RF heating of subcutaneous and dermis will improve acne in needed patients.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- mild-moderate Acne
- age over 18
- otherwise healthy
Key exclusion criteria (4 listed)
- age under 18
- pregnancy
- systemic acne treatment in the last month
- local acne treatment in the last month
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Radio Frequency | Device | – |
Primary outcome
Not reported in the source record.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2020.
Related trials for Acne Vulgaris
Not yet recruitingPhase 3
Evaluation of the Efficacy and Safety of Fractional CO₂ Laser With and Without Intradermal Botulinum Toxin A in the Treatment of Inflammatory Facial Acne Vulgaris.
Acne, Acne Papulopustulosa
RecruitingPhase 4
Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris
Acne
RecruitingPhase 3
Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
Acne Vulgaris
RecruitingPhase 4
Comparing Nadifloxacin Plus Tretinoin Versus Clindamycin Plus Tretinoin Creams for Mild-to-Moderate Acne
Acne Vulgaris
Active, not recruiting
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
Hair Reduction, Tattoo Removal
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yussi Levcelter, Dr. study director
Alma Lasers LTD
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Radio Frequency in people with Acne Vulgaris, run by Alma Lasers at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 9 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2020.